0001666071-21-000157.txt : 20210803
0001666071-21-000157.hdr.sgml : 20210803
20210803160543
ACCESSION NUMBER: 0001666071-21-000157
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210802
FILED AS OF DATE: 20210803
DATE AS OF CHANGE: 20210803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grimes Scott D.
CENTRAL INDEX KEY: 0001617486
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38386
FILM NUMBER: 211139690
MAIL ADDRESS:
STREET 1: CARDLYTICS, INC.
STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardlytics, Inc.
CENTRAL INDEX KEY: 0001666071
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263039436
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
BUSINESS PHONE: 888-798-5802
MAIL ADDRESS:
STREET 1: 675 PONCE DE LEON AVENUE, NE
STREET 2: SUITE 6000
CITY: ATLANTA
STATE: GA
ZIP: 30308
4
1
wf-form4_162802109059963.xml
FORM 4
X0306
4
2021-08-02
0
0001666071
Cardlytics, Inc.
CDLX
0001617486
Grimes Scott D.
C/O CARDLYTICS, INC.
675 PONCE DE LEON AVENUE NE, SUITE 6000
ATLANTA
GA
30308
1
0
0
0
Common Stock
2021-08-02
4
S
0
390
124.39
D
72722
I
See Footnote
Common Stock
2021-08-02
4
S
0
600
126.45
D
72122
I
See Footnote
Common Stock
2021-08-02
4
S
0
910
127.15
D
71212
I
See Footnote
Common Stock
2021-08-02
4
S
0
100
128.09
D
71112
I
See Footnote
Common Stock
237674
D
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019, as amended March 12, 2020.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $124.08 to $124.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5) to this Form 4.
The reportable securities are held by the GRAT.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $125.92 to $126.85, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $126.94 to $127.56, inclusive.
/s/ Kirk Somers, Attorney-in-Fact
2021-08-03